BFM
FLGT icon

Boothbay Fund Management’s Fulgent Genetics FLGT Stock Holding History

Boothbay Fund Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$877K Buy
+42,723
New +$724K 0.01% 1181
2026
Q1 		– Sell
-10,586
Closed -$278K – 2197
2025
Q4 		$278K Sell
10,586
-8,753
-45% -$227K ﹤0.01% 1483
2025
Q3 		$437K Buy
+19,339
New +$398K 0.01% 1245

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boothbay Fund Management's FLGT Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in Fulgent Genetics (FLGT) in Q2 2026: 42,723 shares worth $877K. The stake represents 0.01% of the portfolio and ranks #1181 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in FLGT as recently as Q4 2025.

Boothbay Fund Management first reported a position in FLGT in Q3 2025 and has held it in 3 quarters since. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Boothbay Fund Management held 42,723 shares of Fulgent Genetics worth $877K as of Q2 2026.
  • Fulgent Genetics was a new Boothbay Fund Management position in Q2 2026.
  • Fulgent Genetics made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1181 holding.
  • Boothbay Fund Management first reported a position in Fulgent Genetics in Q3 2025 and has held it in 3 quarters since.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.